Invention Grant
- Patent Title: Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases
-
Application No.: US12151585Application Date: 2008-05-07
-
Publication No.: US08148369B2Publication Date: 2012-04-03
- Inventor: Martin James Inglis Andrews , Mark Stuart Chambers , Wolfgang Schmidt , Giovanni Alessandro Tricarico , Grégory Louis Joseph Bar , Kim Louise Hirst , Olga Raquel Pinto Santos Oliveira Roussel , Juha Andrew Clase
- Applicant: Martin James Inglis Andrews , Mark Stuart Chambers , Wolfgang Schmidt , Giovanni Alessandro Tricarico , Grégory Louis Joseph Bar , Kim Louise Hirst , Olga Raquel Pinto Santos Oliveira Roussel , Juha Andrew Clase
- Applicant Address: BE Beerse
- Assignee: Janssen Pharmaceutica NV
- Current Assignee: Janssen Pharmaceutica NV
- Current Assignee Address: BE Beerse
- Main IPC: A61K31/50
- IPC: A61K31/50 ; A61K31/535 ; C07D413/14 ; C07D471/04
Abstract:
Novel fused pyrazine compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, inflammation, rheumatoid arthritis and others.
Public/Granted literature
- US20090012078A1 Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases Public/Granted day:2009-01-08
Information query
